基于一千例嵌合体胚胎移植结局构建临床胚胎排序系统
该汇总分析纳入5561枚整倍体囊胚和1000枚嵌合体囊胚的临床移植数据,比较植入率、持续妊娠/活产率和自然流产率。整倍体组结局显著优于嵌合体组,且全染色体嵌合水平<50%者优于≥50%者,受累染色体数目越多结局越差。据此提出基于嵌合特征和胚胎形态的嵌合体胚胎优先级排序方案。
要点
- 整倍体胚胎植入率57.2%、持续妊娠/活产率52.3%,均显著优于嵌合体胚胎。
- 全染色体嵌合水平<50%者植入率44.5%、持续妊娠/活产率36.1%,优于≥50%者。
- 嵌合累及染色体数目越多结局越差,可作为临床排序依据。
核心结论
- 嵌合体的水平、类型和受累染色体数目与移植结局显著相关,可据此制定循证排序方案。
研究设计与样本
- 汇总分析,多中心,纳入5561枚整倍体囊胚和1000枚嵌合体囊胚的临床移植数据。
主要发现
- 整倍体组、全部嵌合体组和仅全染色体嵌合组的植入率分别为57.2%、46.5%和41.8%,持续妊娠/活产率分别为52.3%、37.0%和31.3%。
- 整倍体组、全部嵌合体组和仅全染色体嵌合组的自然流产率分别为8.6%、20.4%和25%。
- 全染色体嵌合水平<50%组与≥50%组的植入率分别为44.5%和30.4%,持续妊娠/活产率分别为36.1%和19.3%。
- 从节段性异常嵌合到累及3条及以上染色体的复杂非整倍体,植入率从51.6%降至30.4%,持续妊娠/活产率从43.1%降至20.8%。
临床怎么用
- 临床可综合嵌合水平、嵌合类型和胚胎形态对嵌合体胚胎进行优先级排序,优先移植结局更优的亚类。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study how the attributes of mosaicism identified during preimplantation genetic testing for aneuploidy relate to clinical outcomes, in order to formulate a ranking system of mosaic embryos for intrauterine transfer. DESIGN: Compiled analysis. SETTING: Multi-center. PATIENT(S): A total of 5,561 euploid blastocysts and 1,000 mosaic blastocysts used in clinical transfers in patients undergoing fertility treatment. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Implantation (gestational sac), ongoing pregnancy, birth, and spontaneous abortion (miscarriage before 20 weeks of gestation). RESULT(S): The euploid group had significantly more favorable rates of implantation and ongoing pregnancy/birth (OP/B) compared with the combined mosaic group or the mosaic group affecting only whole chromosomes (implantation: 57.2% vs. 46.5% vs. 41.8%; OP/B: 52.3% vs. 37.0% vs. 31.3%), as well as lower likelihood of spontaneous abortion (8.6% vs. 20.4% vs. 25%). Whole-chromosome mosaic embryos with level (percent aneuploid cells) <50% had significantly more favorable outcomes than the ≥50% group (implantation: 44.5% vs. 30.4%; OP/B: 36.1% vs. 19.3%). Mosaic type (nature of the aneuploidy implicated in mosaicism) affected outcomes, with a significant correlation between number of affected chromosomes and unfavorable outcomes. This ranged from mosaicism involving segmental abnormalities to complex aneuploidies affecting three or more chromosomes (implantation: 51.6% vs. 30.4%; OP/B: 43.1% vs. 20.8%). Combining mosaic level, type, and embryo morphology revealed the order of subcategories regarding likelihood of positive outcome. CONCLUSION(S): This compiled analysis revealed traits of mosaicism identified with preimplantation genetic testing for aneuploidy that affected outcomes in a statistically significant manner, enabling the formulation of an evidence-based prioritization scheme for mosaic embryos in the clinic.
引用
- Viotti M, Victor AR, Barnes FL, et al. Using outcome data from one thousand mosaic embryo transfers to formulate an embryo ranking system for clinical use. Fertil Steril. 2021. PMID: 33685629. doi:10.1016/j.fertnstert.2020.11.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。